Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Shares Outstanding: 2019-2024

Historic Shares Outstanding for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $83.6 million.

  • Beam Therapeutics' Shares Outstanding rose 22.77% to $101.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.4 million, marking a year-over-year increase of 22.77%. This contributed to the annual value of $83.6 million for FY2024, which is 2.45% up from last year.
  • Beam Therapeutics' Shares Outstanding amounted to $83.6 million in FY2024, which was up 2.45% from $81.6 million recorded in FY2023.
  • Beam Therapeutics' Shares Outstanding's 5-year high stood at $83.6 million during FY2024, with a 5-year trough of $57.3 million in FY2020.
  • Moreover, its 3-year median value for Shares Outstanding was $81.6 million (2023), whereas its average is $78.8 million.
  • Data for Beam Therapeutics' Shares Outstanding shows a peak YoY surged of 681.50% (in 2020) over the last 5 years.
  • Over the past 5 years, Beam Therapeutics' Shares Outstanding (Yearly) stood at $57.3 million in 2020, then rose by 19.45% to $68.4 million in 2021, then climbed by 4.22% to $71.3 million in 2022, then grew by 14.53% to $81.6 million in 2023, then grew by 2.45% to $83.6 million in 2024.